New Insights into the Pharmacology and Biodistribution of Gadolinium-based Contrast Agents
- 1 October 2023
- journal article
- editorial
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 309 (1) , e232619
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Gadolinium-based Contrast Agent Biodistribution and Speciation in RatsRadiology, 2023
- Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and GadobenateRadiology, 2021
- Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to ratsJournal of Magnetic Resonance Imaging, 2021
- The Macrocyclic Gadolinium-Based Contrast Agents Gadobutrol and Gadoteridol Show Similar Elimination Kinetics From the Brain After Repeated Intravenous Injections in RabbitsInvestigative Radiology, 2020
- Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium ChelatesRadiology, 2018
- Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium ChelatesRadiology, 2017
- Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to ratsJournal of Magnetic Resonance Imaging, 2017
- Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast AgentsInvestigative Radiology, 2017
- Pharmacokinetics and Tissue Distribution in Animals of Gadobenate Ion, the Magnetic Resonance Imaging Contrast Enhancing Component of Gadobenate Dimeglumine 0.5 M Solution for Injection (MultiHance®)Journal of Computer Assisted Tomography, 1999